Allergan Aesthetics and University Lab Partners Announce NovoThelium as the Winner of the Golden Ticket Pitch Competition

September 13, 2024
Allergan Aesthetics, an AbbVie company

University Lab Partners (ULP) announced NovoThelium as the winner of the 2nd annual Golden Ticket Pitch Competition for aesthetic startups, sponsored by Allergan Aesthetics, an AbbVie company.

This year, five finalists were selected to present their innovative aesthetic technologies to an expert panel of judges, including Charlie Hee, Ph.D., Vice President, Devices, Aesthetics R&D at Allergan Aesthetics; Sherly Soleiman, M.D., Founder, Owner and Lead Injector at Cosmetic Injectable Center; and Michael Hill, Managing Director, Capital Markets at Octane.

“Winning the Golden Ticket from University Lab Partners and Allergan Aesthetics will provide NovoThelium with vital resources and mentorship, enabling us to enhance women’s healthcare and pioneer innovations in nipple reconstruction post-mastectomy,” said Lauren Cornell, PhD, Co-Founder and CEO of NovoThelium.

Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • CGI Digital Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Kentucky Rules Do Not Allow Compounding of Six Peptides Despite HHS Peptide Enforcement Policy
    • AMA Urges HHS to Withdraw Proposal Expanding Access to Certain Unapproved Peptides
    • Health Canada Warns Against Unauthorized Peptides After Bacteria Found in Seized Products
    • Injectable PDGF Enters New Aesthetic Trials for Facial Skin Quality and Infraorbital Hollows